Invesco’s Pulse Biosciences PLSE Stock Holding History

Invesco’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Buy	+10,258	New	+$242K	﹤0.01%	3461
2025 Q1	–	Sell	-214,490	Closed	-$3.73M	–	3803
2024 Q4	$3.73M	Buy	214,490 +204,061	+1,957%	+$3.6M	﹤0.01%	2392
2024 Q3	$183K	Sell	10,429 -382	-4%	-$6.51K	﹤0.01%	3534
2024 Q2	$121K	Buy	+10,811	New	+$102K	﹤0.01%	3725
2021 Q1	–	Sell	-64,956	Closed	-$1.55M	–	3931
2020 Q4	$1.55M	Buy	+64,956	New	+$1.03M	﹤0.01%	2746

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco's PLSE Position: Q2 2026 in Review

Invesco opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 10,258 shares worth $284K. The stake represents ﹤0.01% of the portfolio and ranks #3461 among its holdings. This is a return to the name: Invesco previously reported a position in PLSE as recently as Q4 2024.

Invesco first reported a position in PLSE in Q4 2020 and has held it in 5 quarters since. The position peaked at $3.73M in Q4 2024. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Invesco held 10,258 shares of Pulse Biosciences worth $284K as of Q2 2026.
Pulse Biosciences was a new Invesco position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3461 holding.
Invesco first reported a position in Pulse Biosciences in Q4 2020 and has held it in 5 quarters since.
Invesco's Pulse Biosciences position peaked at $3.73M in Q4 2024.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.